Table 1.

Histopathology results (n = 51)

Benign	23 (45.1%)
Fibroadenoma	15 (29.5%)
Fibrocystic breast changes	6 (11.8%)
Lactating adenoma	1 (1.9%)
Focal pseudoangiomatous stromal hyperplasia (PASH).	1 (1.9%)
Malignant	28 (54.9%)
Invasive ductal carcinoma	18 (35.3%)
Invasive lobular carcinoma	4 (7.9%)
Invasive mammary carcinoma	4 (7.9%)
Ductal carcinoma in situ	1 (1.9%)
Adenocarcinoma*	1 (1.9%)

^*Poorly differentiated adenocarcinoma, morphologically consistent with breast primary. No further analysis available.